← All Sponsors
SPONSOR

Nocion Therapeutics

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Refractory or Unexplained Chronic Cough
NCT06504446 Phase 2
Recruiting

Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough

Refractory or Unexplained Chronic Cough
United States, Belgium, Canada View Trial →